Source: Eur Respir Rev 2013; 22: 103-105
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Luca Richeldi. Idiopathic pulmonary fibrosis: current challenges and future perspectives. Eur Respir Rev 2013; 22: 103-105

Member's Comments

No comment yet.

Related content which might interest you: Idiopathic pulmonary fibrosis: present understanding and future options Source: Eur Respir Rev 2011; 20: 132-133 Year: 2011 Pharmacotherapy for idiopathic pulmonary fibrosis: current landscape and future potential Source: Eur Respir Rev, 26 (145) 170071; 10.1183/16000617.0071-2017 Year: 2017 Idiopathic pulmonary fibrosis: do scientists focus on publishing rather than on clinical relevance? Source: Eur Respir J, 55 (6) 2000811; 10.1183/13993003.00811-2020 Year: 2020 A new era in idiopathic pulmonary fibrosis: considerations for future clinical trials Source: Eur Respir J 2015; 46: 243-249 Year: 2015 Idiopathic pulmonary fibrosis: treatment options in pursuit of evidence-based approaches Source: Eur Respir J 2006; 28: 463-465 Year: 2006 Idiopathic pulmonary fibrosis: recent milestones in disease management Source: Eur Respir Rev 2012; 21: 140 Year: 2012 Best supportive care for idiopathic pulmonary fibrosis: current gaps and future directions Source: Eur Respir Rev, 27 (147) 170076; 10.1183/16000617.0076-2017 Year: 2018 Idiopathic pulmonary fibrosis: approaches to diagnostic Source: Eur Respir J 2002; 20: Suppl. 38, 61s Year: 2002 Current and future therapeutic approaches in idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 26: 693-703 Year: 2005 Sildenafil for pulmonary hypertension complicating idiopathic pulmonary fibrosis: a rationale grounded in basic science Source: Eur Respir J 2016; 47:1615-1617 Year: 2016 Perspectives of therapeutic innovation from current progress in the pathobiology of pulmonary hypertension Source: ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease Year: 2020 What have we learned from basic science studies on idiopathic pulmonary fibrosis? Source: Eur Respir Rev, 28 (153) 190029; 10.1183/16000617.0029-2019 Year: 2019 Recent advances in the pathogenesis and clinical evaluation of pulmonary fibrosis Source: Eur Respir Rev 2012; 21: 48-56 Year: 2012 Pulmonary fibrosis: key features and challenges Source: International Congress 2015 – PG8 Airway and lung fibrosis Year: 2015 Staging of idiopathic pulmonary fibrosis: past, present and future Source: Eur Respir Rev 2014; 23:220-224 Year: 2014 Idiopathic pulmonary fibrosis: from clinical trials to real-life experiences Source: Eur Respir Rev 2015; 24: 420-427 Year: 2015 Patient-centred management in idiopathic pulmonary fibrosis: similar themes in three communication models Source: Eur Respir Rev 2014; 23:231-238 Year: 2014 Idiopathic pulmonary fibrosis: time for greater expectations? Source: Eur Respir J, 52 (2) 1801312; 10.1183/13993003.01312-2018 Year: 2018